Τρίτη 12 Ιουλίου 2016

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

British Journal of Cancer 115, 223 (12 July 2016). doi:10.1038/bjc.2016.106

Authors: Michelle Chin I Lo, Anna Paterson, Jane Maraka, Richard Clark, Joseph Goodwill, Jenny Nobes, Jennifer Garioch, Marc Moncrieff, Ed Rytina & Laszlo Igali



from Cancer via ola Kala on Inoreader http://ift.tt/29PpdbR
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου